T 0801/06 (Cancer treatment with HSV mutant/CRUSADE) of 4.3.2009

European Case Law Identifier: ECLI:EP:BA:2009:T080106.20090304
Date of decision: 04 March 2009
Case number: T 0801/06
Application number: 95927034.9
IPC class: A61K 35/76
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 78 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Treatment of cancer using HSV mutant
Applicant name: Crusade Laboratories Limited; The Wistar Institute of Anatomy and Biology
Opponent name: MediGene Aktiengesellschaft
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention 1973 Art 54
European Patent Convention 1973 Art 56
European Patent Convention 1973 Art 83
European Patent Convention Art 123(2)
Keywords: Added matter (no); sufficiency of disclosure, novelty, inventive step (yes)
Catchwords:

-

Cited decisions:
T 1067/97
T 0753/00
T 0609/02
Citing decisions:
T 1150/09
T 0334/10
T 0801/10
T 1868/16

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t060801eu1.html

Date retrieved: 17 May 2021

6 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Case Law Book: II Conditions to be met by an Application

General Case Law